Mechanisms of triglyceride accumulation in activated macrophages

LPS treatment of macrophages induces TG accumulation, which is accentuated by TG‐rich lipoproteins or FFA. We defined pathways altered during macrophage activation that contribute to TG accumulation. Glucose uptake increased with activation, accompanied by increased GLUT1. Oxidation of glucose markedly decreased, whereas incorporation of glucose‐derived carbon into FA and sterols increased. Macrophage activation also increased uptake of FFA, associated with an increase in CD36. Oxidation of FA was markedly reduced, whereas the incorporation of FA into TGs increased, associated with increased GPAT3 and DGAT2. Additionally, macrophage activation decreased TG lipolysis; however, expression of ATGL or HSL was not altered. Macrophage activation altered gene expression similarly when incubated with exogenous FA or AcLDL. Whereas activation with ligands of TLR2 (zymosan), TLR3 (poly I:C), or TLR4 (LPS) induced alterations in macrophage gene expression, leading to TG accumulation, treatment of macrophages with cytokines had minimal effects. Thus, activation of TLRs leads to accumulation of TG in macrophages by multiple pathways that may have beneficial effects in host defense but could contribute to the accelerated atherosclerosis in chronic infections and inflammatory diseases.

[1]  M. Brown,et al.  Evidence for regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol synthesis in nonhepatic tissues of rat. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[2]  C. Grunfeld,et al.  Nicotinamide and other inhibitors of ADP-ribosylation block deoxyglucose uptake in cultured cells. , 1984, Biochemical and biophysical research communications.

[3]  R. Goldman,et al.  Bacterial lipopolysaccharide suppresses the expression of lipoprotein lipase in murine macrophages: a process independent of tumor necrosis factor or interleukin 1. , 1987, Immunology letters.

[4]  M. Albassam,et al.  Profiles of type-II pneumocytes in rats inoculated intratracheally with bacterial lipopolysaccharide. , 1987, American journal of veterinary research.

[5]  R. Klein,et al.  Low Density Lipoprotein Metabolism in Human Macrophages Stimulated with Microbial or Microbial‐Related Products , 1987, Arteriosclerosis.

[6]  A. Chait,et al.  Bacterial lipopolysaccharide reduces macrophage lipoprotein lipase levels: an effect that is independent of tumor necrosis factor. , 1988, Journal of lipid research.

[7]  S. Grinstein,et al.  Cytoplasmic pH regulation in monocytes and macrophages: mechanisms and functional implications. , 1991, Clinical and investigative medicine. Medecine clinique et experimentale.

[8]  R. Sawyer,et al.  The peritoneal environment during infection. The effect of monomicrobial and polymicrobial bacteria on pO2 and pH. , 1991, Annals of surgery.

[9]  M. Aviram,et al.  Increased susceptibility to activation and increased uptake of low density lipoprotein by cholesterol-loaded macrophages. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[10]  P. Ortiz de Montellano,et al.  Regulation of pathways of extramitochondrial fatty acid oxidation and liver fatty acid-binding protein by long-chain monocarboxylic fatty acids in hepatocytes. Effect of inhibition of carnitine palmitoyltransferase I. , 1993, The Journal of biological chemistry.

[11]  K. Feingold,et al.  Lipopolysaccharide stimulation of RAW 264.7 macrophages induces lipid accumulation and foam cell formation. , 1993, Atherosclerosis.

[12]  J. Spitzer.  Bacterial endotoxin effects on carbohydrate utilization and transport. , 1995, Biochemical Society transactions.

[13]  H. Shinomiya,et al.  Endotoxin-Induced Enhancement of Glucose Influx into Murine Peritoneal Macrophages via GLUT1 , 1995 .

[14]  D. Leake.  Does an acidic pH explain why low density lipoprotein is oxidised in atherosclerotic lesions? , 1997, Atherosclerosis.

[15]  I. Tabas,et al.  Macrophage-targeted CTP:phosphocholine cytidylyltransferase (1-314) transgenic mice. , 1999, Biochimica et biophysica acta.

[16]  S. Akira,et al.  Critical roles of Toll-like receptors in host defense. , 2000, Critical reviews in immunology.

[17]  M. Burnett,et al.  Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[18]  A. Aderem,et al.  Toll-like receptors in the induction of the innate immune response , 2000, Nature.

[19]  H. Lehr,et al.  Immunopathogenesis of Atherosclerosis: Endotoxin Accelerates Atherosclerosis in Rabbits on Hypercholesterolemic Diet , 2000, Circulation.

[20]  D. Scott‐Algara,et al.  Implication of natural killer T cells in atherosclerosis development during a LPS‐induced chronic inflammation , 2002, FEBS letters.

[21]  F. Kraemer,et al.  Hormone-sensitive Lipase: Control of Intracellular Tri-(di-)acylglycerol and Cholesteryl Ester Hydrolysis Structural and Biochemical Properties Thematic Review , 2022 .

[22]  A. Beg,et al.  Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. , 2002, Trends in immunology.

[23]  G. Cooke,et al.  Toll-like receptor 4 polymorphisms and atherogenesis. , 2002, The New England journal of medicine.

[24]  M. Naghavi,et al.  pH Heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque. , 2002, Atherosclerosis.

[25]  B. Beutler.  Innate immune responses to microbial poisons: discovery and function of the Toll-like receptors. , 2003, Annual review of pharmacology and toxicology.

[26]  P. Verpillat,et al.  Association of the Toll-Like Receptor 4 Gene Asp299Gly Polymorphism With Acute Coronary Events , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[27]  P. Pussinen,et al.  Periodontal infections and atherosclerosis: mere associations? , 2004, Current opinion in lipidology.

[28]  S. Akira,et al.  Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Kenneth R Feingold,et al.  Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. , 2004, Journal of lipid research.

[30]  E. Wisse,et al.  Structural changes produced in Kupffer cells in the rat liver by injection of lipopolysaccharide , 2004, Cell and Tissue Research.

[31]  M. Jaye,et al.  Adipophilin Enhances Lipid Accumulation and Prevents Lipid Efflux From THP-1 Macrophages: Potential Role in Atherogenesis , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[32]  Jeffrey B. Boord,et al.  Combined Adipocyte-Macrophage Fatty Acid–Binding Protein Deficiency Improves Metabolism, Atherosclerosis, and Survival in Apolipoprotein E–Deficient Mice , 2004, Circulation.

[33]  S. Imajoh-ohmi,et al.  LPS-induced apoptosis is dependent upon mitochondrial dysfunction , 2004, Apoptosis.

[34]  R. Evans,et al.  A Nuclear Receptor Atlas: macrophage activation. , 2005, Molecular endocrinology.

[35]  P. Tobias,et al.  Modulation of atherosclerosis in mice by Toll-like receptor 2. , 2005, The Journal of clinical investigation.

[36]  K. Feingold,et al.  Adipocyte Fatty Acid–Binding Protein Expression and Lipid Accumulation Are Increased During Activation of Murine Macrophages by Toll-Like Receptor Agonists , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[37]  H. Björkbacka.  Multiple roles of Toll-like receptor signaling in atherosclerosis , 2006, Current opinion in lipidology.

[38]  S. Akira,et al.  TLR signaling. , 2006, Current topics in microbiology and immunology.

[39]  P. Calder,et al.  Glucose metabolism in lymphoid and inflammatory cells and tissues , 2007, Current opinion in clinical nutrition and metabolic care.

[40]  F. Sheedy,et al.  The Troll in Toll: Mal and Tram as bridges for TLR2 and TLR4 signaling , 2007, Journal of leukocyte biology.

[41]  D. Brasaemle.  Thematic review series: Adipocyte Biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis Published, JLR Papers in Press, September 18, 2007. , 2007, Journal of Lipid Research.

[42]  S. Moncada,et al.  Mitochondrial dysfunction and HIF1α stabilization in inflammation , 2008, Journal of Cell Science.

[43]  E. Pivovarova,et al.  Lipid synthesis in macrophages during inflammation in vivo: Effect of agonists of peroxisome proliferator activated receptors α and γ and of retinoid X receptors , 2008, Biochemistry (Moscow).

[44]  P. Bozza,et al.  Lipid bodies in innate immune response to bacterial and parasite infections. , 2008, International immunopharmacology.

[45]  Deborah V Dawson,et al.  Thematic Review Series: Skin Lipids. Antimicrobial lipids at the skin surface Published, JLR Papers in Press, September 28, 2007. , 2008, Journal of Lipid Research.

[46]  David R. Drake,et al.  Antimicrobial lipids at the skin surface , 2007 .

[47]  P. Bozza,et al.  Leukocyte lipid bodies - Biogenesis and functions in inflammation. , 2009, Biochimica et biophysica acta.

[48]  R. Zechner,et al.  Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores , 2009 .

[49]  M. Welte,et al.  PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores. , 2009, Biochimica et biophysica acta.

[50]  C. Erridge,et al.  Toll-like receptor-dependent lipid body formation in macrophage foam cell formation , 2010, Current opinion in lipidology.

[51]  P. Bozza,et al.  Lipid droplet formation in leprosy: Toll‐like receptor‐regulated organelles involved in eicosanoid formation and Mycobacterium leprae pathogenesis , 2010, Journal of leukocyte biology.

[52]  K. Feingold,et al.  ADRP/ADFP and Mal1 expression are increased in macrophages treated with TLR agonists. , 2010, Atherosclerosis.

[53]  V. Fuster,et al.  Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? , 2010, Journal of the American College of Cardiology.

[54]  R. Zechner,et al.  Efficient Phagocytosis Requires Triacylglycerol Hydrolysis by Adipose Triglyceride Lipase , 2010, The Journal of Biological Chemistry.

[55]  G. Pasterkamp,et al.  Endogenous Inflammatory Molecules Engage Toll-Like Receptors in Cardiovascular Disease , 2010, Journal of Innate Immunity.

[56]  S. Young,et al.  Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. , 2011, Cell metabolism.